Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Immunohistochemical Expression and Prognostic Significance of CD97 and its Ligand DAF in Human Cervical Squamous Cell Carcinoma

He, Ying M.Sc.; Wang, Wei M.D.; Xu, Lian B.Sc.; Li, Li; Liu, Juan B.Sc.; Feng, Min M.Sc.; Bu, Hong M.D.

International Journal of Gynecological Pathology: September 2015 - Volume 34 - Issue 5 - p 473–479
doi: 10.1097/PGP.0000000000000200

Accumulating evidences had demonstrated that the CD97, a member of the epidermal growth factor 7-transmembrane family, and its cellular ligand decay accelerating factor (DAF) both play important roles in tumor dedifferentiation, migration, invasiveness, and metastasis. However, the roles of CD97 and DAF in human cervical squamous cell carcinoma (CSCC) have not been investigated. The purpose of this study was to observe the expression profile of CD97 and DAF in CSCC and evaluate their clinical significance. Immunohistochemistry was used to investigate the expression of CD97 and DAF proteins in 97 patients with CSCC and 53 patients with cervical intraepithelial neoplasia, a precursor lesion of CSCC. CD97 and DAF were absent or only weakly expressed in the normal epithelium of the cervix but were present in 83.5% (81/97) and 90.7% (88/97) of CSCC samples, respectively. Overexpression of CD97 was significantly associated with a high International Federation of Gynecology and Obstetrics stage (P=0.010) and lymph node metastasis (P=0.026). The majority of CSCCs, irrespective of staging/grading classification, displayed strong DAF immunostaining. Kaplan-Meier survival analysis revealed that overexpression of CD97 was associated with a worse prognosis. Multivariate analyses showed that the International Federation of Gynecology and Obstetrics stage (P=0.000), lymph node metastasis (P=0.004), and CD97 expression (P=0.040) were independent risk factors for overall survival. The present study suggested that the expressions of CD97 and DAF were both upregulated in CSCC. The expression level of CD97 in CSCC was associated with the severity of the tumor. Furthermore, CD97 might be an independent poor prognostic factor for CSCC patients.

Department of Pathology (Y.H., H.B.)

Laboratory of Pathology (L.L.), West China Hospital of Sichuan University

Department of Pathology (Y.H., W.W., L.X., J.L., M.F.), West China Second Hospital of Sichuan University, Sichuan, China

Y.H. and W.W. contributed equally and should be regarded as cofirst authors.

Supported by Grants from National Natural Science Foundation of China (Grant No. 81101261).

The authors declare no conflict of interest.

Address correspondence and reprint requests to Hong Bu, MD, Department of Pathology, West China Hospital of Sichuan University, No. 37 Guoxuexiang Street, Chengdu, Sichuan 610041, China. E-mail:

©2015International Society of Gynecological Pathologists